INTERNATIONAL PATENT: SHENZHEN KEXING PHARMACEUTICAL CO., LTD., 深圳科兴药业有限公司 FILES APPLICATION FOR "BDCA2-TARGETING ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND USE THEREOF"

GENEVA, Nov. 30 -- SHENZHEN KEXING PHARMACEUTICAL CO., LTD. (Floor 16, Building B, Chuangyi Technology Building, No 198, Keji Middle 1st Road, Nanshan DistrsctShenzhen, Guangdong 518052), 深圳科兴药业有限公司 (中国广东省深圳市南山区科技中一路198号创益科技大厦B栋16楼) filed a patent application (PCT/CN2025/096081) for "BDCA2-TARGETING ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USE THEREOF" on May 20, 2025. With publication no. WO/2025/242094, the details related to the patent application was published on Nov 27, 2025.

Notably, ...